Check-Cap Dividends and Buybacks

Dividend criteria checks 0/6

Check-Cap does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-24.3%

Buyback Yield

Total Shareholder Yield	-24.3%
Future Dividend Yield	n/a
Dividend Growth	n/a
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Payout ratio	n/a

Recent dividend and buyback updates

No updates

Recent updates

Here's Why We're Not Too Worried About Check-Cap's (NASDAQ:CHEK) Cash Burn Situation

May 19

We Think Check-Cap (NASDAQ:CHEK) Can Afford To Drive Business Growth

Feb 03

We're Hopeful That Check-Cap (NASDAQ:CHEK) Will Use Its Cash Wisely

Oct 21

Check-Cap (NASDAQ:CHEK) Is In A Good Position To Deliver On Growth Plans

Jul 01

We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate

Jan 02

Check Cap +1.5% on listing extension from NASDAQ

Dec 30

Check-Cap EPS misses by $0.01

Nov 18

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CHEK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CHEK's dividend payments have been increasing.

Dividend Yield vs Market

Check-Cap Dividend Yield vs Market

How does CHEK dividend yield compare to the market?
Segment	Dividend Yield
Company (CHEK)	n/a
Market Bottom 25% (US)	1.4%
Market Top 25% (US)	4.2%
Industry Average (Medical Equipment)	1.6%
Analyst forecast (CHEK) (up to 3 years)	n/a

Notable Dividend: Unable to evaluate CHEK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CHEK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate CHEK's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CHEK has not reported any payouts.

Check-Cap Dividends and Buybacks

Dividend criteria checks 0/6

Key information

Recent dividend and buyback updates

Recent updates

New minor risk - Share price stability

New major risk - Market cap size

High number of new and inexperienced directors

Check-Cap Ltd. announced delayed 20-F filing

New major risk - Revenue and earnings growth

New minor risk - Share price stability

Nobul AI Corp entered into a definitive Business Combination Agreement to acquire Check-Cap Ltd. (NasdaqCM:CHEK).

Check-Cap Ltd. Announces Executive Changes

Check-Cap Ltd. Announces CFO Changes

Check-Cap Ltd. Announces Resignation of William Vozzolo as Member of the Board of Directors and Independent Member of the Audit Committee

Check-Cap Ltd. Announces Resignation of William Vozzolo as Member of the Board of Directors and Independent Member of the Audit Committee

Symetryx Corporation Recommends Shareholders to Vote Against the Keystone Dental Merger and For its Board Nominees

Symetryx Corporation Discloses its Views on Check-Cap

New major risk - Revenue and earnings growth

SBT Holdings Inc. entered into a definitive Business Combination Agreement to acquire Check-Cap Ltd. (NasdaqCM:CHEK) in a reverse merger transaction.

Check-Cap Ltd. Reports Impairment of Fixed Assets for the Second Quarter Ended June 30, 2023

We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate

Here's Why We're Watching Check-Cap's (NASDAQ:CHEK) Cash Burn Situation

Insufficient new directors

Check-Cap Ltd., Annual General Meeting, Dec 22, 2022

We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate

Check-Cap Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

Here's Why We're Not Too Worried About Check-Cap's (NASDAQ:CHEK) Cash Burn Situation

Check-Cap Ltd. Announces the Initiation of its U.S. Pivotal Trial of C-Scana at Mayo Clinic in Rochester Minnesota

Price target decreased to US$3.00

Insufficient new directors

Check-Cap Ltd. Receives Approval from the U.S. Food and Drug Administration for Its Amended Investigational Device Exemption Application

We Think Check-Cap (NASDAQ:CHEK) Can Afford To Drive Business Growth

Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification

Check-Cap Ltd. Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for Its Colorectal Screening Test, C-Scan

We're Hopeful That Check-Cap (NASDAQ:CHEK) Will Use Its Cash Wisely

Check-Cap (NASDAQ:CHEK) Is In A Good Position To Deliver On Growth Plans

No longer forecast to breakeven

Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

New 90-day high: US$2.33

New 90-day high: US$1.85

We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate

New 90-day high: US$0.43

Check Cap +1.5% on listing extension from NASDAQ

New 90-day high: US$0.41

Check-Cap EPS misses by $0.01

New 90-day low: US$0.31

New 90-day low: US$0.34

New 90-day low - US$0.39

New 90-day high - US$0.80

Stability and Growth of Payments

Dividend Yield vs Market

Earnings Payout to Shareholders

Cash Payout to Shareholders

Discover strong dividend paying companies